InvestorsHub on MSN

Evaxion Biotech Shares Jump Following MSD Vaccine Licensing Deal

Evaxion Biotech AS (NASDAQ:EVAX) surged 33% in premarket trading Thursday after announcing that MSD (NYSE:MRK) has exercised its option to license Evaxion’s vaccine candidate EVX-B3. Under the ...
TipRanks on MSN

Evaxion Out-Licenses Vaccine Candidate EVX-B3 to MSD

Evaxion Biotech ( ($EVAX) ) just unveiled an announcement. On September 25, 2025, Evaxion A/S announced the out-licensing of its vaccine candidate ...